[Federal Register Volume 64, Number 187 (Tuesday, September 28, 1999)]
[Notices]
[Pages 52335-52336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-25204]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 52336]]
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Health Services Research Subcommittee.
Date: October 13, 1999.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburgh, MD 20878.
Contact Person: Marina L. Volkov, PhD, Special Expert, Office of
Extramural Program Review, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room
3158, Msc 9547, Bethesda, MD 20892-9547, (301) 435-1433.
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Treatment Research Subcommittee.
Date: October 13, 1999.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Kesinee Nimit, MD, Health Scientist
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001
Executive Boulevard, Room 3158, Msc 9547, Bethesda, MD 20892-9547,
(301) 435-1432.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Treatment Research.
Date: October 13, 1999.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Susan L. Coyle, PhD, Chief, Clinical,
Epidemiological and Applied Sciences Review Branch, Office of
Extramural Program Review, National Institute on Drug Abuse,
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room
3158, Msc 9547, Bethesda, MD 20892-9547, (301) 443-2620.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Program Projects Review Committee.
Date: November 2, 1999.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA
22209.
Contact Person: Rita Liu, PhD, Health Scientist Administrator,
Office of Extramural Program Review, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 3158, Msc 9547, Bethesda, MD 20892-9547, (301) 443-
2620.
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Training and Career Development Subcommittee.
Date: November 3-5, 1999.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington West End Marriott, 1221 22nd Street, NW,
Washington, DC 20037.
Contact Person: Mark Swieter, PhD, Health Scientist
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001
Executive Boulevard, Room 3158, Msc 9547, Bethesda, MD 20892-9547,
(301) 435-1389.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Centers Review Committee.
Date: November 3, 1999.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA
22209.
Contact Person: Rita Liu, PhD, Health Scientist Administrator,
Office of Extramural Program Review, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 3158, Msc 9547, Bethesda, MD 20892-9547, (301) 443-
2620.
Name of Committee: National Institute on Drug Abuse Initial
Review Group, Medication Development Research Subcommittee.
Date: November 3, 1999.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Bethesda, MD 20814.
Contact Person: Khursheed, Asghar, PhD, Chief, Basic Sciences
Review Branch, Office of Extramural Program Review, National
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001
Executive Boulevard, Room 3158, Msc 9547, Bethesda, MD 29089-2954,
(301) 443-2620.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Training and Career Development.
Date: November 5, 1999.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington West End Marriott, 1221 22nd Street, NW
Washington, DC 20037.
Contact Person: Khursheed, Asghar, PhD, Chief, Basic Sciences
Review Branch, Office of Extramural Program Review, National
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001
Executive Boulevard, Room 3158, Msc 9547, Bethesda, MD 29089-2954,
(301) 443-2620.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, SPIRCAP.
Date: November 16-17, 1999.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Bethesda, MD 20814.
Contact Person: Khursheed, Asghar, PhD, Chief, Basic Sciences
Review Branch, Office of Extramural Program Review, National
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001
Executive Boulevard, Room 3158, Msc 9547, Bethesda, MD 29089-2954,
(301) 443-2620.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse Research Programs, National Institutes of Health,
HHS)
Dated: September 21, 1999.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 99-25204 Filed 9-27-99; 8:45 am]
BILLING CODE 4140-01-M
